Privia Health Group, Inc. PRVA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Privia Health Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Privia Health Group, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Privia Health Group, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Privia Health Group, Inc.'s cash & equivalents?
- Privia Health Group, Inc. (PRVA) reported cash & equivalents of $419.52M in Q1 2026.
- How has Privia Health Group, Inc.'s cash & equivalents changed year-over-year?
- Privia Health Group, Inc.'s cash & equivalents decreased by 10.6% year-over-year, from $469.33M to $419.52M.
- What is the long-term trend for Privia Health Group, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Privia Health Group, Inc.'s cash & equivalents has grown at a 41.5% compound annual growth rate (CAGR), from $84.63M to $479.69M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.